I’m a bit out over my skis here, but given that we’ve just seen an active pandemic mutate to become more infectious, it does make some sense to try and anticipa

I’m a bit out over my skis here, but given that we’ve just seen an active pandemic mutate to become more infectious, it does make some sense to try and anticipate what else might happen next. This kind of research has obvious biowarfare implications, so it should obviously be carefully monitored and regulated internationally. As far as successful examples, I’m not really sure. But I’m not convinced that I’d take a lack of examples as proof of unsuitability; we’re clearly in a new era of viral and immunology research. Given that researchers can literally sequence proteins for mRNA vaccine use, a ludicrous concept even a decade ago to most of us, I suspect that attempting to anticipate future mutations via gain of function research might yield more medicinal rewards than it would have in decades past.